ESMO Public Policy

Celebrate ESMO’s 2011 achievement of the recognition of the profession of medical oncology in Europe. Locate national contact points for working across borders, and find answers to FAQs.

Find out how ESMO supports protecting data privacy as well as the collection and use of patient data for retrospective clinical research, biobanks, and population-based disease registries.

Discover how ESMO actively facilitates clinical cancer research, including input into the EU Clinical Trials Regulation, the founding of CAREFOR to safeguard clinical academic cancer research, and ESMO’s offering of research fellowships and clinical trials workshops.

Learn about ESMO’s study to improve working conditions and quality control procedures in order to protect healthcare workers from the adverse effects of occupational exposure to anti-cancer medicines.

Follow the ESMO-initiated multi-stakeholder partnerships in Europe and Asia that propose solutions to eliminate hurdles faced by rare cancer patients, researchers, medical professionals and the pharmaceutical industry working in this field.

With over 24% of ESMO members practicing in Asia-Pacific, ESMO has launched policy activities such as Rare Cancers Asia and will address public policy challenges in the region with data collection, position papers, and educational activities.

Learn about ESMO’s position on a wide range of legislative and non-legislative policy files on both EU and global levels. Discover ESMO’s contributions that shape policy and legislation for the oncology community.